DOUBLE MEDICAL TECHNOLOGY INC. Financials Double Medical Technology Inc.
Equities
002901
CNE1000032W7
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.92 CNY | -1.23% |
|
-6.68% | -28.75% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 20,310 | 14,062 | 16,805 | 11,973 | - | - |
| Enterprise Value (EV) 1 | 20,310 | 14,062 | 16,805 | 11,973 | 11,973 | 11,973 |
| P/E ratio | 30.3 x | 155 x | 290 x | 39.1 x | 25.7 x | 19.2 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 10.2 x | - | 11 x | 5.94 x | 4.64 x | 3.89 x |
| EV / Revenue | 10.2 x | - | 11 x | 5.94 x | 4.64 x | 3.89 x |
| EV / EBITDA | 22.6 x | - | 58.4 x | 21.7 x | 16.1 x | 12.5 x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Price to Book | 8.08 x | - | 5.49 x | 3.67 x | 3.32 x | 2.96 x |
| Nbr of stocks (in thousands) | 401,232 | 413,232 | 414,020 | 414,020 | - | - |
| Reference price 2 | 50.62 | 34.03 | 40.59 | 28.92 | 28.92 | 28.92 |
| Announcement Date | 3/29/22 | 4/28/23 | 3/29/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1,994 | - | 1,533 | 2,016 | 2,579 | 3,080 |
| EBITDA 1 | 897.8 | - | 287.5 | 552 | 743 | 956 |
| EBIT 1 | 822 | - | 103.2 | 455.5 | 676.5 | 906 |
| Operating Margin | 41.22% | - | 6.73% | 22.59% | 26.23% | 29.42% |
| Earnings before Tax (EBT) 1 | 802.5 | - | 99.74 | 449.5 | 672.5 | 902 |
| Net income 1 | 673.3 | - | 58.97 | 305 | 466 | 625 |
| Net margin | 33.76% | - | 3.85% | 15.13% | 18.07% | 20.29% |
| EPS 2 | 1.670 | 0.2200 | 0.1400 | 0.7400 | 1.125 | 1.505 |
| Free Cash Flow | - | - | - | - | - | - |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/29/22 | 4/28/23 | 3/29/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 |
|---|---|
| Net sales 1 | 427.3 |
| EBITDA | - |
| EBIT | - |
| Operating Margin | - |
| Earnings before Tax (EBT) | - |
| Net income 1 | 61.73 |
| Net margin | 14.45% |
| EPS | - |
| Dividend per Share | - |
| Announcement Date | 4/29/24 |
1CNY in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
| ROE (net income / shareholders' equity) | 26.7% | 1.95% | 9.35% | 12.9% | 15.4% |
| ROA (Net income/ Total Assets) | - | - | 5.4% | 6.2% | 7.6% |
| Assets 1 | - | - | 5,648 | 7,516 | 8,224 |
| Book Value Per Share 2 | 6.260 | 7.390 | 7.880 | 8.710 | 9.780 |
| Cash Flow per Share 2 | 1.670 | - | 0.6000 | 1.640 | 1.970 |
| Capex 1 | - | 304 | 400 | 350 | 330 |
| Capex / Sales | - | 19.84% | 19.84% | 13.57% | 10.71% |
| Announcement Date | 3/29/22 | 3/29/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
28.92
CNY
Average target price
41
CNY
Spread / Average Target
+41.77%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -28.75% | 1.65B | |
| +13.31% | 129B | |
| -9.90% | 10.92B | |
| -2.59% | 8.5B | |
| +37.50% | 5.5B | |
| -22.36% | 4.69B | |
| -11.25% | 2.73B | |
| -14.85% | 2B | |
| -13.29% | 1.93B | |
| -7.38% | 1.16B |
- Stock Market
- Equities
- 002901 Stock
- Financials Double Medical Technology Inc.
